Company intelligence / Profile preview
Shanghai Bintie Biotechnology Co., Ltd.
Shanghai, Shanghai, Chinaimmuxell.cn ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Shanghai Bintie Biotechnology is a clinical-stage biotech company developing novel immunocyte preparations—primarily T-cell receptor-based therapies—targeting solid tumors with a focus on recurrent/refractory cancers such as pancreatic cancer. Their approach involves identifying TCRs that recognize shared driver gene mutations or tumor neoantigens, aiming to create both personalized and off-the-shelf cell therapies. The lead program is in Phase I trials targeting KRAS-mutated pancreatic ductal adenocarcinoma.
- Therapeutic areas
- Oncology
- Modalities
- T-cell receptor (TCR) cell therapiesImmunocyte preparations targeting solid tumors
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
No major pharmaceutical or biotech partnerships are publicly disclosed.
Beyond the preview
Go deeper on Shanghai Bintie Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Bintie Biotechnology Co., Ltd..